vs

Side-by-side financial comparison of ImmunityBio, Inc. (IBRX) and Rumble Inc. (RUM). Click either name above to swap in a different company.

ImmunityBio, Inc. is the larger business by last-quarter revenue ($38.3M vs $27.1M, roughly 1.4× Rumble Inc.). Rumble Inc. runs the higher net margin — -120.8% vs -161.8%, a 41.0% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs -10.5%). Rumble Inc. produced more free cash flow last quarter ($-31.7M vs $-71.3M).

ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.

Rumble is a Canadian-American online video platform, web hosting, and cloud services business headquartered in Toronto, Canada, with its U.S. headquarters in Longboat Key, Florida. It was founded in 2013 by Chris Pavlovski, a Canadian technology entrepreneur. Rumble's cloud services business hosts Truth Social, and the video platform is popular among American conservative and far-right users. Rumble has been described as "alt-tech".

IBRX vs RUM — Head-to-Head

Bigger by revenue
IBRX
IBRX
1.4× larger
IBRX
$38.3M
$27.1M
RUM
Growing faster (revenue YoY)
IBRX
IBRX
+417.4% gap
IBRX
407.0%
-10.5%
RUM
Higher net margin
RUM
RUM
41.0% more per $
RUM
-120.8%
-161.8%
IBRX
More free cash flow
RUM
RUM
$39.6M more FCF
RUM
$-31.7M
$-71.3M
IBRX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IBRX
IBRX
RUM
RUM
Revenue
$38.3M
$27.1M
Net Profit
$-61.9M
$-32.7M
Gross Margin
99.0%
5.5%
Operating Margin
-169.0%
-131.1%
Net Margin
-161.8%
-120.8%
Revenue YoY
407.0%
-10.5%
Net Profit YoY
-4.7%
86.2%
EPS (diluted)
$-0.06
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IBRX
IBRX
RUM
RUM
Q4 25
$38.3M
$27.1M
Q3 25
$32.1M
$24.8M
Q2 25
$26.4M
Q1 25
$16.5M
$23.7M
Q4 24
$7.6M
$30.2M
Q3 24
$6.1M
$25.1M
Q2 24
$22.5M
Q1 24
$17.7M
Net Profit
IBRX
IBRX
RUM
RUM
Q4 25
$-61.9M
$-32.7M
Q3 25
$-67.3M
$-16.3M
Q2 25
$-92.6M
Q1 25
$-129.6M
$-2.7M
Q4 24
$-59.2M
$-236.8M
Q3 24
$-85.7M
$-31.5M
Q2 24
$-26.8M
Q1 24
$-43.3M
Gross Margin
IBRX
IBRX
RUM
RUM
Q4 25
99.0%
5.5%
Q3 25
99.4%
-1.8%
Q2 25
99.5%
Q1 25
99.6%
-26.7%
Q4 24
-14.2%
Q3 24
-45.4%
Q2 24
-58.8%
Q1 24
-79.5%
Operating Margin
IBRX
IBRX
RUM
RUM
Q4 25
-169.0%
-131.1%
Q3 25
-173.5%
-113.6%
Q2 25
-269.8%
Q1 25
-390.1%
-153.5%
Q4 24
-919.0%
-80.1%
Q3 24
-1314.3%
-131.0%
Q2 24
-172.7%
Q1 24
-197.4%
Net Margin
IBRX
IBRX
RUM
RUM
Q4 25
-161.8%
-120.8%
Q3 25
-209.8%
-65.7%
Q2 25
-350.3%
Q1 25
-784.9%
-11.2%
Q4 24
-783.4%
-783.2%
Q3 24
-1404.0%
-125.9%
Q2 24
-119.2%
Q1 24
-244.1%
EPS (diluted)
IBRX
IBRX
RUM
RUM
Q4 25
$-0.06
$-0.13
Q3 25
$-0.07
$-0.06
Q2 25
$-0.10
Q1 25
$-0.15
$-0.01
Q4 24
$-0.08
$-1.17
Q3 24
$-0.14
$-0.15
Q2 24
$-0.13
Q1 24
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IBRX
IBRX
RUM
RUM
Cash + ST InvestmentsLiquidity on hand
$242.8M
$237.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$-500.5M
$274.8M
Total Assets
$501.9M
$336.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IBRX
IBRX
RUM
RUM
Q4 25
$242.8M
$237.9M
Q3 25
$257.8M
$269.8M
Q2 25
$153.7M
Q1 25
$61.6M
$301.3M
Q4 24
$149.8M
$114.0M
Q3 24
$130.4M
$132.0M
Q2 24
$154.2M
Q1 24
$183.8M
Stockholders' Equity
IBRX
IBRX
RUM
RUM
Q4 25
$-500.5M
$274.8M
Q3 25
$-524.3M
$302.2M
Q2 25
$-570.7M
Q1 25
$-591.4M
$339.6M
Q4 24
$-489.1M
$-63.1M
Q3 24
$-745.1M
$166.1M
Q2 24
$192.7M
Q1 24
$210.7M
Total Assets
IBRX
IBRX
RUM
RUM
Q4 25
$501.9M
$336.8M
Q3 25
$519.0M
$367.2M
Q2 25
$402.1M
Q1 25
$303.8M
$391.1M
Q4 24
$382.9M
$195.3M
Q3 24
$364.6M
$217.2M
Q2 24
$243.2M
Q1 24
$263.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IBRX
IBRX
RUM
RUM
Operating Cash FlowLast quarter
$-70.4M
$-29.4M
Free Cash FlowOCF − Capex
$-71.3M
$-31.7M
FCF MarginFCF / Revenue
-186.2%
-117.2%
Capex IntensityCapex / Revenue
2.4%
8.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-308.8M
$-70.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IBRX
IBRX
RUM
RUM
Q4 25
$-70.4M
$-29.4M
Q3 25
$-68.9M
$-10.6M
Q2 25
$-79.7M
Q1 25
$-85.9M
$-14.5M
Q4 24
$-85.1M
$-12.4M
Q3 24
$-98.8M
$-19.1M
Q2 24
$-21.7M
Q1 24
$-33.9M
Free Cash Flow
IBRX
IBRX
RUM
RUM
Q4 25
$-71.3M
$-31.7M
Q3 25
$-69.6M
$-12.0M
Q2 25
$-80.8M
Q1 25
$-87.0M
$-14.6M
Q4 24
$-87.3M
$-12.4M
Q3 24
$-101.6M
$-19.9M
Q2 24
$-23.1M
Q1 24
$-34.3M
FCF Margin
IBRX
IBRX
RUM
RUM
Q4 25
-186.2%
-117.2%
Q3 25
-217.2%
-48.6%
Q2 25
-305.9%
Q1 25
-526.9%
-61.7%
Q4 24
-1155.4%
-40.9%
Q3 24
-1663.2%
-79.5%
Q2 24
-102.8%
Q1 24
-193.3%
Capex Intensity
IBRX
IBRX
RUM
RUM
Q4 25
2.4%
8.5%
Q3 25
2.3%
5.7%
Q2 25
4.1%
Q1 25
6.8%
0.6%
Q4 24
28.0%
0.1%
Q3 24
45.7%
3.4%
Q2 24
6.1%
Q1 24
2.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IBRX
IBRX

Segment breakdown not available.

RUM
RUM

Audience Monetization$23.8M88%
Other Initiatives$3.3M12%

Related Comparisons